Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 6/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30360196 | 0.96 | ALDH1A1 (0.39) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13096929 | 0.96 | ALDH1A1 (0.39) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL18317969 | 0.88 | ALDH1A1 (0.42) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13096928 | 0.88 | ALDH1A1 (0.44) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL20689734 | 0.87 | ALDH1A1 (0.37) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL25346422 | 0.83 | ALDH1A1 (0.38) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL16326511 | 0.83 | ALDH1A1 (0.46) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL16326510 | 0.82 | ALDH1A1 (0.42) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL13024869 | 0.82 | TSHR (0.40) | ALDH1A1TP53HIF1ACYP3A4MAPK1 | |
| SCHEMBL16326509 | 0.81 | ALDH1A1 (0.44) | ALDH1A1TP53HIF1ACYP3A4MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230129152-A1 | Compounds Comprising Perfluorinated Group, Photoinitiator Group, and Amide Linking Group | 3M INNOVATIVE PROPERTIES COMPANY | 2023-04-27 | — | — | US | disclosed |
| US-20230129152-A1 | Compounds Comprising Perfluorinated Group, Photoinitiator Group, and Amide Linking Group | 3M INNOVATIVE PROPERTIES COMPANY | 2023-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230129152-A1 | Compounds Comprising Perfluorinated Group, Photoinitiator Group, and Amide Linking Group | PFAS, AFF4, AFF1 | ALDH1A1 988/4885TP53 1212/4885HIF1A 4434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.